Venclexta (venetoclax)

pCPA File Number: 22992

Negotiation Status:

Active Negotiation

Indication(s):

for the treatment of adult patients with previously untreated chronic lymphocytic leukemia (CLL), including those with 17p deletion (in combination with Imbruvica)

Sponsor/Manufacturer:

AbbVie Corporation

CDA-AMC Project Number:

PC0317-000

pCPA Engagement Letter Issued:

2024-12-05

Negotiation Process Concluded:

Not Applicable